SARM1 and infection: In this cohort, levels of CD68 staining in sciatic nerves did not differ between mice injected with SARM1V184G and the control SARM1 AAV (Additional File 5), nor did any of the mice display significant myelin defects or vacuolization in the sural, sciatic or tibial nerves 3–4 days post-infection (data not shown).